Cargando…
In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters
Due to the many beneficial properties combined from both poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) and liposomes, lipid-PLGA hybrid NPs have been intensively studied as cancer drug delivery systems, bio-imaging agent carriers, as well as antigen delivery vehicles. However, the impact...
Autores principales: | Hu, Yun, Ehrich, Marion, Fuhrman, Kristel, Zhang, Chenming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154617/ https://www.ncbi.nlm.nih.gov/pubmed/25232295 http://dx.doi.org/10.1186/1556-276X-9-434 |
Ejemplares similares
-
(131)I-Traced PLGA-Lipid Nanoparticles as Drug Delivery Carriers for the Targeted Chemotherapeutic Treatment of Melanoma
por: Wang, Haiyan, et al.
Publicado: (2017) -
Single-step assembly of polymer-lipid hybrid nanoparticles for mitomycin C delivery
por: Yi, Yunfeng, et al.
Publicado: (2014) -
Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery
por: Wu, Zhi Min, et al.
Publicado: (2012) -
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
por: Chen, Hongbo, et al.
Publicado: (2010) -
Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery
por: Benizri, Sebastien, et al.
Publicado: (2018)